98%
921
2 minutes
20
Histone H3K4 modifications are altered in the regulation of gene expression and in multiple cellular processes during cancer development and progression. Understanding the roles of H3K4-modifying enzymes will provide novel insights into therapeutic tools for cancer treatment. H3K4-modifying enzymes catalyze the addition or removal of covalent modifications with specific substrate preferences. Although these proteins are evolutionarily conserved between yeast and mammals, their protein domains and functions are not identical, and they exhibit signs of evolutionary divergence. Recent studies have indicated that H3K4-modifying enzymes play non-canonical roles via non-histone substrates or non-catalytic functions. Here, we discuss both canonical and non-canonical functions of H3K4-modifying enzymes and their potential benefits for therapeutic applications in cancer therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/cas.70190 | DOI Listing |
Cancer Sci
September 2025
Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Histone H3K4 modifications are altered in the regulation of gene expression and in multiple cellular processes during cancer development and progression. Understanding the roles of H3K4-modifying enzymes will provide novel insights into therapeutic tools for cancer treatment. H3K4-modifying enzymes catalyze the addition or removal of covalent modifications with specific substrate preferences.
View Article and Find Full Text PDFEpigenomes
June 2021
Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 11529, Taiwan.
During the process of aging, extensive epigenetic alterations are made in response to both exogenous and endogenous stimuli. Here, we summarize the current state of knowledge regarding one such alteration, H3K4 methylation (H3K4me), as it relates to aging in different species. We especially highlight emerging evidence that links this modification with metabolic pathways, which may provide a mechanistic link to explain its role in aging.
View Article and Find Full Text PDFCell
August 2018
Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, 13(th) Street, Charlestown, MA 02129, USA. Electronic address:
Acquired chromosomal DNA amplifications are features of many tumors. Although overexpression and stabilization of the histone H3 lysine 9/36 (H3K9/36) tri-demethylase KDM4A generates transient site-specific copy number gains (TSSGs), additional mechanisms directly controlling site-specific DNA copy gains are not well defined. In this study, we uncover a collection of H3K4-modifying chromatin regulators that function with H3K9 and H3K36 regulators to orchestrate TSSGs.
View Article and Find Full Text PDF